Research Focus

Former Employee. Research and Technology Management; Clinical Research Supervisor

Recent additions – View all

1. The majority of patients with relapsing light chain (AL) amyloidosis are not eligible for enrollment onto clinical trials: Using screen failures to define major unmet medical needs

   Meeting Abstract

   Landau, H.; Comenzo, R. L.; Balasinorwala, T.; Warner, M.; Landgren, O.; Giralt, S. A.; Hassoun, H.
   Blood (2015)

   Fulltext@MSK | Save